SuspendedNot Applicable

Probiotics and GBS Colonization in Pregnancy

Stopped: Uneffective

Italy402 participantsStarted 2020-10-15

Plain-language summary

Multicentric, randomized, placebo-controlled, double-blind, parallel group study aimed at evaluating the feasibility and effect of the use of probiotic starting from the 30th week, on vaginal / rectal colonization of GBS in women at low obstetric risk.

Who can participate

Age range18 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * low obstetric risk pregnant women by the 33rd week of gestation, * vaginal delivery expected. Exclusion Criteria: * positive urine culture for GBS, * previous newborn suffering from early sepsis, * use of antibiotics in the month prior to enrollment, * women unable to understand the study and sign informed consent.

What they're measuring

GBS Rectovaginal colonization

Timeframe: at 35-37 weeks

Trial details

NCT IDNCT05156333

SponsorUniversity of Modena and Reggio Emilia

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-09-30

View on ClinicalTrials.gov More GBS Rectovaginal Colonization trials